Literature DB >> 20087233

The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease.

Xinxin Yang1, Lu Song, Zhenguo Liu.   

Abstract

This study was undertaken to investigate the neuroprotective effects of repetitive transcranial magnetic stimulation (rTMS) on 6-hydroxydopamine (6-OHDA)-induced rats with Parkinson's disease. rTMS was given to rats with Parkinson's disease induced by 6-OHDA, daily for 4 weeks to examine the protective effects. Rotational test showed that rTMS significantly attenuated apomorphine-induced turns in rats with Parkinson's disease. Tissue processing showed that rTMS alleviated 6-OHDA-induced loss of dopaminergic neurons in rat substantia nigra. Furthermore, rTMS decreased the levels of cyclooxygenase-2 and tumor necrosis factor-alpha in rat substantia nigra, and prevented the fall of dopamine in the striatum of rats with Parkinson's disease.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20087233     DOI： 10.1097/WNR.0b013e328335b411

Source DB:  PubMed          Journal:  Neuroreport        ISSN： 0959-4965            Impact factor:   1.837


  12 in total

Review 1.  Modulation of cortical inhibition by rTMS - findings obtained from animal models.

Authors:  Klaus Funke; Alia Benali
Journal:  J Physiol       Date:  2011-07-18       Impact factor: 5.182

2.  High-Frequency Repetitive Transcranial Magnetic Stimulation Regulates Astrocyte Activation by Modulating the Endocannabinoid System in Parkinson's Disease.

Authors:  Xin Kang; Bing Zhang; Wanqing Du; Rui Zhao; Xuedong Liu; Ya Bai; Xiaobing Jiang; Jie Pang; Chenguang Zhao; Xiang Mou; Fang Gao; Hua Yuan; Xiaolong Sun
Journal:  Mol Neurobiol       Date:  2022-06-07       Impact factor: 5.682

Review 3.  Benefits from Repetitive Transcranial Magnetic Stimulation in Post-Stroke Rehabilitation.

Authors:  Michał Starosta; Natalia Cichoń; Joanna Saluk-Bijak; Elżbieta Miller
Journal:  J Clin Med       Date:  2022-04-12       Impact factor: 4.964

4.  Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.

Authors:  Ji Yong Lee; Hyun Soo Kim; Sung Hoon Kim; Han-Soo Kim; Byung Pil Cho
Journal:  Tissue Eng Regen Med       Date:  2020-01-22       Impact factor: 4.169

Review 5.  Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats.

Authors:  Andrew M Vahabzadeh-Hagh; Paul A Muller; Roman Gersner; Abraham Zangen; Alexander Rotenberg
Journal:  Neuromodulation       Date:  2012-07-10

Review 6.  Novel Neuromodulation Techniques to Assess Interhemispheric Communication in Neural Injury and Neurodegenerative Diseases.

Authors:  Samuel S Shin; Galit Pelled
Journal:  Front Neural Circuits       Date:  2017-03-09       Impact factor: 3.492

7.  Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats.

Authors:  Tsung-Hsun Hsieh; Xiao-Kuo He; Hui-Hua Liu; Jia-Jin J Chen; Chih-Wei Peng; Hao-Li Liu; Alexander Rotenberg; Ko-Ting Chen; Ming-Yuan Chang; Yung-Hsiao Chiang; Pi-Kai Chang; Chi-Wei Kuo
Journal:  Neural Plast       Date:  2021-12-27       Impact factor: 3.599

8.  Repetitive transcranial magnetic stimulation for treatment of lactacystin-induced Parkinsonian rat model.

Authors:  Maowen Ba; Guozhao Ma; Chao Ren; Xuwen Sun; Min Kong
Journal:  Oncotarget       Date:  2017-04-20

9.  Repetitive transcranial magnetic stimulation (rTMS) improves behavioral and biochemical deficits in levodopa-induced dyskinetic rats model.

Authors:  Maowen Ba; Min Kong; Lina Guan; Maoli Yi; Hongli Zhang
Journal:  Oncotarget       Date:  2016-09-13

Review 10.  Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review).

Authors:  Shahid Bashir; Mohammad Uzair; Turki Abualait; Muhammad Arshad; Roaa A Khallaf; Asim Niaz; Ziyad Thani; Woo-Kyoung Yoo; Isaac Túnez; Asli Demirtas-Tatlidede; Sultan Ayoub Meo
Journal:  Mol Med Rep       Date:  2022-02-04       Impact factor: 2.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.